{
  "metadata": {
    "system": "QSight",
    "version": "1.0",
    "generated_at": "2026-01-02T23:28:36.542515"
  },
  "patient_info": {
    "id": 10,
    "name": "Test Patient",
    "age": 45,
    "sex": "M",
    "bmi": 24.49,
    "vascular_risk": false
  },
  "image_info": {
    "left_eye": "left_eye.jpg",
    "right_eye": "right_eye.jpg",
    "resolution": "224x224"
  },
  "model_info": {
    "model": "DR-CNN",
    "framework": "PyTorch",
    "task": "Diabetic Retinopathy Classification"
  },
  "diagnosis_info": {
    "left_eye": "Mild",
    "right_eye": "Mild",
    "confidence": 85.5,
    "risk_score": 4.0
  },
  "llm_report": {
    "condition_overview": "Diabetic retinopathy (DR) is microvascular damage to the retina from diabetes. Mild DR observed in both eyes (OU). Confidence: 85.5%.",
    "patient_assessment": "45-year-old male with mild bilateral DR. Primary risk factor: Insulin-dependent diabetes. Favorable factors: Healthy BMI, non-smoker, low alcohol intake, no overt vascular disease. Risk score 4.0 indicates ongoing risk for progression.",
    "implications": "Risk of DR progression to proliferative DR, diabetic macular edema. Potential for severe vision loss, blindness if untreated. Systemic microvascular compromise likely present.",
    "treatment_plan": {
      "Medical Management": [
        "Optimize glycemic control (HbA1c target <7%).",
        "Maintain blood pressure <130/80 mmHg.",
        "Manage dyslipidemia (LDL target <100 mg/dL)."
      ],
      "Ophthalmologic Monitoring": [
        "Dilated fundus examination every 6-12 months.",
        "Optical coherence tomography (OCT) as indicated."
      ],
      "Lifestyle Guidance": [
        "Diet: Emphasize low glycemic index foods, limit saturated fats, increase antioxidant-rich vegetables/fruits.",
        "Eye protection: Wear UV-blocking sunglasses outdoors.",
        "Glycemic control: Consistent medication adherence, regular blood glucose monitoring.",
        "Physical activity: Regular moderate exercise.",
        "Smoking cessation: Critical for vascular health (patient advised to maintain non-smoker status).",
        "Alcohol moderation: Continue low intake."
      ]
    },
    "life_impact": [
      "Currently minimal visual impairment.",
      "Potential for future blurry vision, floaters.",
      "Future impact on driving, reading, fine visual tasks possible."
    ],
    "financial_impact": {
      "Monitoring Costs": [
        "Regular ophthalmologic examinations.",
        "Retinal imaging (OCT, DFE)."
      ],
      "Therapy Costs": [
        "Potential future anti-VEGF injections, laser photocoagulation, vitrectomy surgery."
      ],
      "Systemic Management Costs": [
        "Ongoing diabetes medication, primary care visits, endocrinology consultations."
      ]
    },
    "recovery_projection": "With stringent glycemic, blood pressure, lipid control, and regular ophthalmologic follow-up, disease progression can be slowed or halted. Vision stabilization is expected. Regression of mild DR is possible. Non-adherence risks rapid progression and irreversible vision loss.",
    "additional_assessments": [
      "Referral to endocrinology for diabetes optimization.",
      "Referral to primary care for comprehensive systemic risk factor management.",
      "Baseline HbA1c, lipid panel, renal function tests."
    ],
    "compliance_notice": "Strict adherence to medical regimen, lifestyle modifications, and scheduled ophthalmologic follow-ups is critical to preserve vision."
  }
}